Clinical Trial Update: Trial to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Vaccine in Healthy Infants [Phase 2]

View source ↗

Summary

Phase 2 trial update on safety and immunogenicity of a multivalent pneumococcal vaccine in healthy infants completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumococcal Infections

Drugs mentioned

• Pfizer multivalent pneumococcal vaccine

Snippet

Sponsor: Pfizer | Conditions: Pneumococcal Infections | Phase 2 | Status: COMPLETED | Results posted: 2021-03-02